Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8534905 | Life Sciences | 2018 | 6 Pages |
Abstract
Our data indicated upregulated lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt/SREBP-2/HMGCR pathway, and implied that lncARSR may serve as a therapeutic target for cholesterol disorder.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jiabin Huang, Shangjun Chen, Dongliang Cai, Deqiang Bian, Fengling Wang,